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Background: Parkinson’s disease (PD) is a neurodegenerative movement disorder
associated with gait and balance problems and a substantially increased risk of falling.
Falls occur often during complex movements, such as turns. Both fear of falling (FOF)
and previous falls are relevant risk factors for future falls. Based on recent studies
indicating that lab-based and home assessment of similar movements show different
results, we hypothesized that FOF and a positive fall history would influence the
quantitative turning parameters differently in the laboratory and home.
Methods: Fifty-five PD patients (43 underwent a standardized lab assessment; 40
were assessed over a mean of 12 days at home with approximately 10,000 turns per
participant; and 28 contributed to both assessments) were classified regarding FOF
and previous falls as “vigorous” (no FOF, negative fall history), “anxious” (FOF, negative
fall history), “stoic” (no FOF, positive fall history) and “aware” (FOF, positive fall history).
During the assessments, each participant wore a sensor on the lower back.
Results: In the lab assessment, FOF was associated with a longer turning duration and
lowered maximum and middle angular velocities of turns. In the home evaluations, a lack
of FOF was associated with lowered maximum and average angular velocities of turns.
Positive falls history was not significantly associated with turning parameters, neither in
the lab nor in the home.
Conclusion: FOF but not a positive fall history influences turning metrics in PD
patients in both supervised and unsupervised environments, and this association is
different between lab and home assessments. Our findings underline the relevance of
comprehensive assessments including home-based data collection strategies for fall
risk evaluation.
Keywords: home assessment, inertial measurement unit, Parkinson’s disease, quantitative assessment, turning
INTRODUCTION
Up to 68% of patients with Parkinson’s disease (PD) fall at least once a year (Canning et al., 2009;
Voss et al., 2012; Fasano et al., 2017). Falls reduce patient quality of life and could lead to severe
injuries, such as hip fractures (Voss et al., 2012; Yang et al., 2016). Deficits in turning performance
contribute relevantly to the occurrence and frequency of falls in patients with this disease
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(King et al., 2012; Yang et al., 2016). This association between
turning deficits and fall frequency is most likely due to
the complexity of the movement. Turning requires inter-limb
coordination, complex coupling between posture and gait, and
continuous, dynamic movement of the individual’s center of
gravity (Cheng et al., 2014; Mellone et al., 2016). Recent studies
performed in a supervised environment show that PD patients
tend to turn slower, with more steps and a reduced turning angle
than controls do (El-Gohary et al., 2013; Cheng et al., 2014;
Mellone et al., 2016). Moreover, PD patients show a simultaneous
rotation of the head, thorax, and pelvis during turning (they move
“en bloc”) (Crenna et al., 2007; Mellone et al., 2016; Yang et al.,
2016). This axial rigidity may further increase lateral instability
during this movement. A narrower base of support which leads
to an external, unbalanced center of gravity during the turn,
resulting in a higher risk of falling, may also contribute to an
increased fall risk during turning in this population (Mellone
et al., 2016).
Recent studies have indicated that fear of falling (FOF) (Allen
et al., 2013; Fasano and Bloem, 2013; Bryant et al., 2014; Almeida
et al., 2015) and a positive history of falls (Bloem et al., 2001;
Pickering et al., 2007; Voss et al., 2012; Allen et al., 2013; Bryant
et al., 2014) contribute to future falls in PD patients. The influence
of FOF on future falls has also been demonstrated in non-PD
cohorts, including cohorts with a poor balance status and reduced
mobility function (Mak and Pang, 2009; Delbaere et al., 2010a). In
this context, it is relevant to note that PD patients clearly have
higher FOF scores than older adults without PD (Pham et al.,
2017).
Based on this information, we evaluated the impact of FOF
and a history of falls on quantitative parameters of turning in
both supervised and unconstrained environments. We included
both environments due to the following reasons: (i) assessment
performed in the habitual environment may reflect the person’s
usual performance and may have a higher relevance for our
understanding of the health-related quality of life of a patient
than assessments performed in a doctor’s office or a scientific
laboratory (El-Gohary et al., 2013; Giannouli et al., 2016; van
Uem et al., 2016; Zhang et al., 2017), and (ii) the use of a
novel technique allows the collection of the activity patterns of
PD patients in the home environment with validated algorithms
(El-Gohary et al., 2013; Mancini et al., 2015; Pham et al., 2017).
There is increasing evidence that parameters of similar activities,
assessed in one person first in the laboratory and then in the
home environment may substantially differ (Toosizadeh et al.,
2015; Giannouli et al., 2016; Zhang et al., 2017). We hypothesized
that both factors, FOF and a history of falls, independently affect
turning metrics in both environments.
MATERIALS AND METHODS
Study Cohort Demographics and Clinical
Assessments
The ABC-PD study (amyloid-beta in cerebrospinal fluid as a
risk factor for cognitive dysfunction in Parkinson’s disease)
was approved by the ethics committee of the Medical Faculty
of the University of Tübingen (protocol no. 686/2013BO1)
and was performed in accordance with the ethical standards
outlined in the 1964 Declaration of Helsinki and its later
amendments.
We obtained informed consent from 55 PD patients prior to
enrolment. All of the patients fulfilled the following inclusion
criteria: 50–85 years of age, diagnosis of PD according to the UK
Brain-Bank criteria, and an ability to communicate well with the
investigator and to understand and comply with the requirements
of the study. Dementia served as an exclusion criterion (Emre
et al., 2007). Forty-three subjects (31 males and 12 females, mean
age: 67; Table 1) were included in the lab-based substudy, and
40 subjects (29 males and 11 females, mean age: 67; Table 2)
were included in the home-based evaluation. Twenty-eight of the
participants contributed to both substudies, which allowed us to
intra-individually compare lab-collected turning parameters with
those collected at home (Table 3).
Patients in the lab-based assessment were measured during
their medication ON phase, i.e., during the study participant’s
perception of having a good “on” phase after regular intake of
medication (Elshehabi et al., 2016).
All participants were assessed with the motor part of the
Unified Parkinson’s Disease Rating Scale (MRS-UPDRS-III)
(Goetz et al., 2008), the Hoehn and Yahr (H&Y) Scale (Hoehn
and Yahr, 1967), the Mini-Mental-State-Examination (MMSE)
(Folstein et al., 1975), and the Freezing of Gait Questionnaire
(Vogler et al., 2015). FOF was assessed with the German version
of the Falls Efficacy Scale-International (FES-I) (Yardley et al.,
2005). Fall history was assessed with a semi-structured interview
by asking the participants about occurrence and frequency of
falls during the last 12 months (Heinzel et al., 2016). A FES-I
score of 19 (cut-off between low and moderate/high FOF cut-
point) (Delbaere et al., 2010b), and two falls in the preceding
year served as cut off values. All participants also underwent
lumbar puncture and cerebrospinal fluid amyloid-beta1−42 was
evaluated.
Turning Assessment in the Lab
In this substudy, PD patients performed two instrumented Timed
up and Go (iTUG) trials over a walking distance of 7 m at
convenient gait pace. The iTUG includes two 180◦ turns: one
during walking, and one when sitting down again. Data was
assessed with a Mobility Lab R© inertial measurement unit (IMU)
at the lower back (OPAL system, APDM, Inc., Portland, OR,
United States).
Turning Assessment at Home
In this substudy, PD patients continuously wore a small IMU
(RehaGait R©, Hasomed, Magdeburg) in an elastic belt at the lower
back for a median of 12 days. The feasibility and usability of this
procedure have recently been demonstrated in an independent
PD cohort (Ferreira et al., 2015; van Uem et al., 2016).
Data Extraction
For the detection of turns and the extraction of turn metrics
in both substudies, we used a recently published algorithm
developed by our group (Pham et al., 2017). The turn metrics
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TABLE 1 | Demographic, clinical, and iTUG data in the lab assessment.
“The vigorous”
FOF−
“The anxious”
FOF+
“The stoic”
FOF−
“The aware”
FOF+
p-value Cohort
Previous falls− Previous falls− Previous falls+ Previous falls+
N (female) 18 (5) 12 (3) 8 (3) 5 (1) 0.86 43 (12)
Age (years) 65 ± 10 64 ± 19 68 ± 9 67 ± 6 0.85 65 ± 12
UPDRS III1 (0–132) 21 (10–34) 31 (15–56) ∗ 23 (18–39) (‡) 30 (26–42) (∗) 0.003 27 (10–56)
H&Y (1–5) 4/13/1/0/0 0/11/1/0/0 2/6/0/0/0 2/1/2/0/0 0.05 8/31/4/0/0
MMSE1 (0–30) 28 (25–30) 28 (24–30) 29 (24–30) 29 (27–30) 0.57 28 (24–30)
FES-I1 (0–64) 17 (16–19) 23 (20–35) ∗ 17 (16–19) ‡ 27 (21–29) ∗ # 0.0001 18 (16–35)
Disease duration1 (years) 5 (2–15) 6 (3–13) 4 (3–5) 5 (2–10) 0.18 5 (2–15)
Freezing of gait (yes vs. no)
(Vogler et al., 2015)
y:4, n:14 y:5, n:7 y:2, n:6 y:2, n:3 0.38 y:13, n:30
Levodopa equivalent dose1
(mg)
415 (100–1055) 650 (220–1550) 525 (180–756) 457 (400–980) 0.19 460 (100–1550)
CSF-amyloid-beta1−42 (normal
vs. lowered) (Palmqvist et al.,
2014)
n:10, l:8 n:5, l:7 n:2, l:6 n:2, l:3 0.53 n:19, l:24
iTUG turn 1
Turn duration (s) 2.34 ± 0.53 2.85 ± 0.67 2.25 ± 0.56 3.44 ± 1.09 ∗ # 0.02 2.59 ± 0.74
Turn angle (◦) 183 ± 7 178 ± 9 181 ± 4 172 ± 12 0.16 180 ± 8
Average angular velocity (◦/s) 81 ± 18 71 ± 15 78 ± 16 58 ± 13 0.20 75 ± 17
Maximum angular velocity (◦/s) 157 ± 33 133 ± 28 163 ± 24 117 ± 35 0.07 147 ± 33
Start angular velocity (◦/s) 29 ± 20 23 ± 14 19 ± 10 32 ± 13 0.43 26 ± 16
Middle angular velocity (◦/s) 123 ± 32 122 ± 38 143 ± 24 81 ± 28 (‡) # 0.02 122 ± 35
End angular velocity (◦/s) 24 ± 11 17 ± 7 21 ± 7 23 ± 12 0.72 21 ± 10
iTUG turn 2
Turn duration (s) 4.15 ± 0.56 4.94 ± 0.72 4.41 ± 0.81 6.07 ± 1.79 ∗ (‡) # 0.002 4.64 ± 1.03
Turn angle (◦) 180 ± 7 174 ± 11 177 ± 6 177 ± 4 0.88 177 ± 8
Average angular velocity (◦/s) 72 ± 16 61 ± 15 71 ± 16 50 ± 14 0.22 66 ± 17
Maximum angular velocity (◦/s) 152 ± 43 115 ± 22 (∗) 147 ± 17 95 ± 17 ∗ (#) 0.03 134 ± 37
Start angular velocity (◦/s) 26 ± 17 22 ± 13 24 ± 8 19 ± 14 0.97 24 ± 14
Middle angular velocity (◦/s) 116 ± 32 91 ± 31 95 ± 44 70 ± 18 0.26 100 ± 36
End angular velocity (◦/s) 8 ± 3 9 ± 4 12 ± 7 8 ± 5 0.29 9 ± 5
Calculations were performed with ANOVA and a post hoc Student’s t-tests (demographic and clinical data), and with a linear regression model corrected for gender, and
UPDRS III (iTUG data). In case of non-normally distributed data1, data are presented with median and range, and calculations were performed with the Kruskal–Wallis
and post hoc Wilcoxon tests. Statistically significant differences are marked in bold. Post hoc analyses were Bonferroni corrected (p < 0.05/4 = 0.0125). Post hoc values
0.0125 ≤ p<0.05 are presented in brackets. ∗ Against “the vigorous”; ‡ against “the anxious”; # against “the stoic.” CSF, cerebrospinal fluid; FES-I, The Falls Efficacy
Scale International; FOF, fear of falling; H&Y, Hoehn and Yahr stage; MMSE, Mini-Mental-State-Examination; iTUG, instrumented Timed up and Go Test; UPDRS III, Unified
Parkinson’s Disease Rating Scale.
were duration, angle, average angular velocity, starting angular
velocity, middle angular velocity, ending angular velocity and
maximum angular velocity of every turn. Start and end angular
velocity were defined as the mean of the absolute value of the first
or final 10 samples at the beginning or end of a turn, respectively.
The middle angular velocity was defined as the mean of the
absolute value of 10 samples at the middle of a turn. For the
home environment data, the original definition of a turn (0.1–
10 s duration, >90◦) (Pham et al., 2017) was slightly adapted
to increase the probability of identifying “true” turns in our
analysis. We removed turns with a duration <0.5 s and >5.0 s,
with an average angular velocity <20◦/s and >360◦/s and with a
maximum angular velocity <20◦/s and >720◦/s.
Statistical Analysis
We used JMP 11.2 software for statistical analysis. According
to Delbaere et al. (2010a), we divided the overall cohort into
the following four groups based on absence or presence of FOF
and negative or positive fall history: “the vigorous” (i.e., without
FOF and with negative fall history), “the anxious” (with FOF
and negative fall history), “the stoic” (without FOF and with
positive fall history) and “the aware” (with FOF and positive
fall history). Demographic and clinical inter-group differences
were calculated using ANOVA and post hoc Student’s t-test,
except for gender, H&Y, freezing of gait, and CSF-amyloid-
beta1−42, which were analyzed using chi-squared test. Shapiro–
Wilk W test was used to test normality of data, and in case
of non-normally distributed data, calculations were performed
with the Kruskal–Wallis and post hoc Wilcoxon test. The results
are presented as the mean and standard deviation, median
and range, or proportion of the total. Due to the known
disease severity and gender effects on turns (Haaxma et al.,
2007), we evaluated the quantitative turning data with a linear
regression model corrected for UPDRS III and gender. We did
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TABLE 2 | Demographic, clinical, and quantitative turning data in the home assessment.
“The vigorous”
FOF−
“The anxious”
FOF+
“The stoic”
FOF−
“The aware”
FOF+
p-value Cohort
Previous falls− Previous falls− Previous falls+ Previous falls+
N (female) 19 (5) 10 (2) 6 (2) 5 (2) 0.48 40 (11)
Age (years) 66 ± 9 65 ± 6 68 ± 8 66 ± 8 0.95 66 ± 8
UPDRS III1 (0–132) 21 (10–38) 29 (15–56) 23 (15-30) 29 (15-30) 0.06 23 (10-56)
H&Y (1–5) 2/15/2/0/0 9/1/0/0/0 2/4/0/0/0 2/1/2/0/0 0.07 6/29/5/0/0
MMSE1 (0–30) 28 (25–30) 28 (24–30) 29 (24–30) 28 (26–30) 0.51 28 (24–30)
FES-I1 (0–64) 16 (16–19) 23 (20–35) ∗ 17 (16–19) ‡ 27 (25–41) ∗ ‡# 0.0001 18 (16–41)
Disease duration1 (years) 4 (2–15) 6 (3–13) 3 (2–5) 5 (2–12) 0.13 4 (2–15)
Freezing of gait (yes/no) (Vogler
et al., 2015)
y:4, n:15 y:4, n:6 y:2, n:4 y:2, n:3 0.64 y:12, n:28
Levodopa equivalent dose1
(mg)
415 (100–1055) 735 (220–1252) 460 (100–715) 429 (400–1338) 0.11 457 (100–1338)
CSF amyloid-beta1−42
(normal vs. lowered)
(Palmqvist et al., 2014)
n:9, l:10 n:2, l:8 n:2, l:4 n:4, l:1 0.14 n:17, l:23
Duration of measurement
(days)1
12 ± 2 12 ± 2 12 ± 2 13 ± 1 0.63 12 ± 2
Number of turns/day1 787 ± 366 912 ± 635 770 ± 299 710 ± 341 0.60 804 ± 417
Turn angle (◦) 122 ± 3 121 ± 3 119 ± 2 118 ± 5 0.11 121 ± 3
Turn duration (s) 2.47 ± 0.23 2.49 ± 0.19 2.71 ± 0.26 2.38 ± 0.33 0.07 2.50 ± 0.25
Average angular velocity (◦/s) 59 ± 6 59 ± 5 52 ± 6 (∗) (‡) 61 ± 8 # 0.04 58 ± 6
Maximum angular velocity (◦/s) 183 ± 18 185 ± 9 167 ± 14 (∗) (‡) 194 ± 20 # 0.04 182 ± 17
Start angular velocity (◦/s) 24 ± 6 23 ± 4 20 ± 5 25 ± 6 0.34 23 ± 5
Middle angular velocity (◦/s) 73 ± 13 77 ± 6 68 ± 6 79 ± 10 0.23 74 ± 11
End angular velocity (◦/s) 25 ± 5 25 ± 4 22 ± 4 28 ± 5 0.33 25 ± 5
Calculations were performed with ANOVA and a post hoc Student’s t-tests (demographic and clinical data), and with a linear regression model corrected for gender, and
UPDRS III (quantitative turning data). In case of non-normally distributed data1, data are presented with median and range and calculations were performed with the
Kruskal–Wallis and post hoc Wilcoxon tests. Statistically significant differences are marked in bold. Post hoc analyses were Bonferroni corrected (p < 0.05/4 = 0.0125).
Post hoc values 0.0125 ≤ p < 0.05 are presented in brackets. ∗ Against “the vigorous”; ‡ against “the anxious”; # against “the stoic.” CSF, cerebrospinal fluid; FES-I,
The Falls Efficacy Scale International; FOF, fear of falling; H&Y, Hoehn and Yahr stage; MMSE, Mini-Mental-State-Examination; iTUG, instrumented Timed up and Go Test;
UPDRS III, Unified Parkinson’s Disease Rating Scale.
not include further parameters that could potentially influence
turning metrics (such as LEDD, cerebrospinal fluid amyloid-
beta1−42 level, or presence and severity of freezing of gait)
in the model, as they did not significantly differ between
groups (see below). The results are presented as the least
squares mean and standard deviation. All post hoc analyses
were Bonferroni corrected (0.05/4) since we performed four
comparisons across groups that were considered relevant for the
actual research question: anxious against vigorous and aware
against stoic to evaluate the effect of FOF; stoic against vigorous
and aware against anxious to evaluate the effect of fall history.
For comparison between the lab and home assessments, we
divided the home-based parameters by the respective lab-based
parameters in those 28 patients who provided both home and
lab data (Table 3). For this purpose, we used the means of both
iTUG turns. This combination reflects, in our view, best the home
situation.
RESULTS
In the lab-based substudy, we found that aware PD patients had
a significantly longer least squares mean of turning durations
during both turns of the iTUG compared to the stoic group (first
turn, p = 0.002; second turn, p = 0.001). Accordingly, during the
first turn, the middle angular velocity was lower in the aware PD
patients than in the stoic ones (p = 0.04). During the second
turn, the maximum angular velocity was lower in the anxious
PD patients than in the vigorous PD patients (p = 0.04), and
also lower in the aware PD patients than in the stoic patients
(p = 0.014). We did not observe relevant differences between
patient groups with and without positive fall history. Details are
presented in Table 1.
From the home-based substudy, a mean of 9,664 turns per
participant were included in the analysis. The only differences
among all the quantitative turning parameters that remained
significant after post hoc Bonferroni correction were the
maximum and average angular velocities between the aware and
stoic PD patients (p = 0.008 and p = 0.01, respectively, with lower
values in the stoic PD patients). Table 2 provides details regarding
the turning metrics in the home environment.
The ratios between the home-based and the lab-based
maximum and middle angular velocities were significantly
different between the stoic and the aware PD patients (p = 0.005
and p = 0.004, respectively). The stoic PD patients turned at home
approximately half as fast as during the lab assessment (ratio of
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TABLE 3 | Ratio of turning parameters in the home versus the lab assessment.
“The vigorous”
FOF−
“The anxious”
FOF+
“The stoic”
FOF−
“The aware”
FOF+
p-value Cohort
Previous falls− Previous falls− Previous falls+ Previous falls+
N (female) 13 (4) 7 (1) 5 (2) 3 (0) 0.52 28 (7)
Age (years) 65 ± 10 65 ± 7 67 ± 8 64 ± 10 0.98 65 ± 9
UPDRS III1 (0–132) 21 (10–33) 28 (15–37) 25 (19–30) 29 (26–30) 0.09 23 (10–37)
H&Y (1–5) 1/11/1/0/0 0/1/6/0/0 1/4/0/0/0 2/0/1/0/0 0.50 4/21/3/0/0
MMSE1 (0–30) 28 (25–30) 28 (27–30) 29 (24–30) 30 (27–30) 0.74 29 (24–30)
FES-I1 (0–64) 17 (16–18) 22 (20–35)∗ 17 (16–19)‡ 28 (27–29)∗ # 0.0001 18 (16–35)
Disease duration1 (years) 5 (2–15) 5 (3–13) 3 (2–5) 4 (2–5) 0.23 4 (2–15)
Freezing of gait (yes/no) (Vogler
et al., 2015)
y:3, n:10 y:2, n:5 y:2, n:3 y:1, n:2 0.98 y:8, n:20
Levodopa equivalent dose1
(mg)
415 (100–1055) 690 (220–1252) 500 (375–715) 420 (400–457) 0.24 460 (100–1252)
CSF amyloid-beta1−42 (normal
vs. lowered) (Palmqvist et al.,
2014)
n:8, l:5 n:2, l:5 n:2, l:3 n:2, l:1 0.47 n:14, l:14
Turn duration (ratio) 0.75 ± 0.12 0.71 ± 0.06 0.82 ± 0.14 0.63 ± 0.10 0.07 0.74 ± 0.12
Average angular velocity (ratio) 0.77 ± 0.11 0.80 ± 0.12 0.71 ± 0.14 0.95 ± 0.02 0.07 0.79 ± 0.13
Maximum angular velocity
(ratio)
1.25 ± 0.19 1.33 ± 0.22 1.11 ± 0.16 1.58 ± 0.04 (∗) # 0.036 1.28 ± 0.22
Start angular velocity (ratio) 1.03 ± 0.49 1.12 ± 0.76 0.85 ± 0.32 0.85 ± 0.21 0.70 1.00 ± 0.51
Middle angular velocity (ratio) 0.63 ± 0.13 0.67 ± 0.13 0.60 ± 0.15 0.95 ± 0.25 ∗ (‡) # 0.027 0.67 ± 0.17
End angular velocity (ratio) 1.64 ± 0.53 1.61 ± 0.34 1.47 ± 0.35 1.55 ± 0.53 0.92 1.59 ± 0.44
Calculations of the ratios of turns performed in the lab [mean of two turns as performed during the instrumented Timed up and Go (iTUG) test, see text for details] and
at home (i.e., home parameter divided by respective lab parameter) were performed with a linear regression model corrected for gender and UPDRS III. Statistically
significant differences are marked in bold. Post hoc analyses were Bonferroni corrected (p < 0.05/4 = 0.0125). Post hoc values 0.0125 ≤ p < 0.05 are presented in
brackets. ∗ Against “the vigorous”; ‡ against “the anxious”; # against “the stoic.”
FIGURE 1 | Fear of falling, but not a positive history of falls, induces changes
of turning parameters in patients with Parkinson’s disease, regardless of
history of previous falls and whether the turns are evaluated in the lab or the
home. Significant differences compared to respective other groups (black
arrows) are displayed with open arrows. Larger size of the open arrow
indicates changes of turning parameters in direction “faster, more dynamic
turn,” smaller size in direction “slower, less dynamic turn.”
home/lab = 0.60), whereas the aware patients showed virtually
similar turning velocities under observed and unobserved
conditions (ratio of home/lab = 0.95, Table 3). Figure 1 provides
an overview of the results.
DISCUSSION
To the best of our knowledge, this study is the first to focus
on quantitative turning parameters in relation to FOF and a
history of falls in PD patients. It shows that (1) FOF changes
turning parameters, regardless of history of previous falls and (2)
assessments should combine home and lab data, since they seem
to bring different and potentially complementary information
(Figure 1).
FOF Changes Turning Parameters in PD
Patients
Fear of falling does not only arise from previous falls; it
is associated with the progression of the disease’s severity, a
perceived imbalance based on dopaminergic medication and
could be a psychological response to the diagnosis of PD
(e.g., caused by near fall experiences and freezing of gait)
(Bryant et al., 2014; de Souza et al., 2015). Several studies have
reported that FOF is a substantial predictor of future falls,
thus emphasizing the relevance of considering FOF for fall risk
assessment in PD patients (Friedman et al., 2002; Pickering
et al., 2007; Mak and Pang, 2009; Bryant et al., 2014). The
situation is similar for the factor of a “positive history of
falls” (Ashburn et al., 2001; Bloem et al., 2001; Almeida et al.,
2015). The aim of the study was thus to determine whether
FOF and a positive history of falls influence the quantitative
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turning parameters in PD based on previous assumptions that
turning performance may be closely linked to fall occurrence
and frequency (Cheng et al., 2014; Mellone et al., 2016; Yang
et al., 2016; Fasano et al., 2017). Our results obtained in a lab
environment demonstrate that aware PD patients turn slower
than vigorous PD patients. This is in line with previous studies
(Mak and Pang, 2009; Delbaere et al., 2010a; Bryant et al.,
2014). However, this comparison does not allow a separation
between the specific effects of FOF and a history of falls during
turning. We therefore used a recently introduced approach for
investigating these distinct associations in more detail (Pham
et al., 2017). With this approach, we could determine that FOF –
but not a positive falls history – has a relevant impact on
the turning metrics in PD insofar as it was associated with
obviously less stable turning behavior. In more detail, among
the fallers, the aware PD patients (i.e., those with FOF) showed
longer turn durations and lower middle angular velocities of
turns, compared to the stoic patients (i.e., those without FOF).
A trend toward the same direction was observable among the
non-fallers. These results are supported by results obtained
from the comparison of anxious (i.e., those without history of
falls but with FOF) with stoic (i.e., those with history of falls
but without FOF) PD patients. The anxious patients showed
a longer turn duration and a lower maximum and middle
angular velocity. As disease-associated factors and measures,
such as MMSE, FOG, disease duration, LDEE and amyloid-
beta values were not different across groups, and we corrected
for motor impairment (i.e., MDS-UPDRS III), we suggest that
our finding is not explained by these factors. Moreover, our
results are in agreement with outcomes described in previous
prospective studies showing that FOF has a negative impact
on gait and balance in PD patients, regardless of previous
falls (Rahman et al., 2011; Bryant et al., 2014). Due to FOF,
PD patients have been shown in these studies to change gait
speed, postural stability and general freedom of movement and
action (Adkin et al., 2003; Mak and Pang, 2009; Lindholm
et al., 2014). Future studies should evaluate whether selective
interventions addressing FOF can lower fall risk and the number
of falls in PD, specifically through an influence on turning
performance.
Different and Potentially Complementary
Information From Lab and Home
Assessment
Moreover, we were interested in whether an extensive assessment
performed at home shows different results from the lab-based
assessment, as there is increasing evidence that these two
assessment strategies show substantially different, and at least
partly complementary results (Fasano et al., 2017). In the home-
collected data, we found partly opposing information to the
data obtained in the lab. The stoic PD patients who showed
a shorter turn duration and a higher angular turn velocity
in the supervised (lab) environment compared to the aware
PD patients presented with a lower average and maximum
angular turn velocity in the home environment. We hypothesize
that this effect is best explained by the use of different
strategies during supervised movements (reflecting mostly
physical capacity) and unsupervised movements (reflecting
mostly physical activity). Our hypothesis is built on the following
two observations: (i) physical capacity and physical activity
domains do not highly correlate (Van Lummel et al., 2015;
Giannouli et al., 2016; Zhang et al., 2017) and (ii) there is
evidence of an increased activation of central compensatory
networks in prodromal PD and clinical PD to address
(involuntary, potentially reflecting “physical activity”-associated)
motor deficits. (Buhmann et al., 2005; van Nuenen et al.,
2012). Therefore, there may exist at least a subtype of patients
that forces the affected patients to use the “physical capacity”
mode instead of the “physical activity” mode for the successful
performance of daily activities. Conversely, stoic PD patients
demonstrated good physical capacity in the lab performance
but obviously adapted their turning expenditures in the home
environment to an extent that is less energy consuming. As
our study design does not allow us to test for interaction
effects and causal relationships, our interpretations need to
be further investigated in future prospective and longitudinal
studies that focus on a better understanding of axial impairment
and milestones such as falls in PD (Puschmann et al.,
2015).
Positive Fall History Does Not Relevantly
Influence Turning Parameters
Interestingly, a positive fall history did not contribute to an
altered turning performance in our cohort. Although this lack
of significant association might be explained by the relatively
small sample size, the general assumption is that FOF has a
more relevant influence on turning measures than a positive fall
history in PD patients, both in the lab and at home. This result
should motivate to a broad assessment strategy, including FOF
aspects, in future studies focusing on mobility in this patient
cohort.
As a general comment, most of our PD patients had relatively
low H&Y stages, and the inclusion of PD patients with more
advanced disease stages might have led to different results. Still,
our study suggests that early treatment of FOF during the disease
may prevent from future falls in at least a subgroup of PD
patients.
CONCLUSION
Our study suggests that FOF, much more than a positive
fall history, has a relevant impact on turning metrics in
PD patients under supervised and unsupervised conditions.
It is thus probable that FOF contributes substantially to
unsafe walking and can predict falls in PD patients. The
opposing associations between FOF and the angular turn
velocity measures in the supervised and unconstrained
environments, as observed in the anxious and stoic PD
patients, suggest that these two groups use different turning
strategies during supervised and unsupervised assessment
phases. Therefore, future studies in PD should include
information from the lab in combination with data obtained from
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the home environment, as the latter data may be –at least partly–
complementary to lab data.
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